Psychiatric genetics and genomics have made major strides in recent years. Some of that knowledge has yet to permeate in the clinical practice of biological psychiatry. The example of cancer-genetics, biology and clinical treatments may be profitable in terms of accelerating translational integration in psychiatry. We propose that current developments in genetics and genomics point to an Early Low-Dose Rational Polypharmacy in Oligopopulations model for psychiatric pharmacotherapy.
|Original language||English (US)|
|Number of pages||4|
|State||Published - Dec 1 2006|
- Biological psychiatry
- Personalized medicine
ASJC Scopus subject areas
- Psychiatry and Mental health